Image placeholder title

Liquid Biopsies Replacing Tissue-based Tests and Improving Treatment

Liquid biopsies improve access to treatment options for many cancers and may replacing tissue tests & diagnostic imaging

Image placeholder title

Tumor Mutational Burden Predicts for Response to Immuotherapy in NSCLC

Research suggests that tumor mutational burden assessment can help predict response to immunotherapy in NSCLC.

Image placeholder title

Amivantamab Treatment of EGFR Positive Non-Small Cell Lung Cancer

Amivantamab targets Non-Small Cell Lung Cancer with cancer causing EGFR Exon 20 Insertion Mutations